These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32598969)

  • 1. TGF-β1 maintains Foxp3 expression and inhibits glycolysis in natural regulatory T cells via PP2A-mediated suppression of mTOR signaling.
    Chen X; Feng L; Li S; Long D; Shan J; Li Y
    Immunol Lett; 2020 Oct; 226():31-37. PubMed ID: 32598969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells with TGF-β1 and IL-2 differentiate naive CD4+ T cells into alloantigen-specific and allograft protective Foxp3+ regulatory T cells.
    Yang H; Cheng EY; Sharma VK; Lagman M; Chang C; Song P; Ding R; Muthukumar T; Suthanthiran M
    Transplantation; 2012 Mar; 93(6):580-8. PubMed ID: 22270834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
    J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells.
    Strainic MG; Shevach EM; An F; Lin F; Medof ME
    Nat Immunol; 2013 Feb; 14(2):162-71. PubMed ID: 23263555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT6 Inhibits TGF-beta1-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor.
    Takaki H; Ichiyama K; Koga K; Chinen T; Takaesu G; Sugiyama Y; Kato S; Yoshimura A; Kobayashi T
    J Biol Chem; 2008 May; 283(22):14955-62. PubMed ID: 18400747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro-expanded CD4(+)CD25(high)Foxp3(+) regulatory T cells controls corneal allograft rejection.
    Guo X; Jie Y; Ren D; Zeng H; Zhang Y; He Y; Pan Z
    Hum Immunol; 2012 Nov; 73(11):1061-7. PubMed ID: 22939904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidylcholine enhances the suppressive function of human naturally occurring regulatory T cells through TGF-β production.
    Hasegawa H; Lei J; Matsumoto T; Onishi S; Suemori K; Yasukawa M
    Biochem Biophys Res Commun; 2011 Nov; 415(3):526-31. PubMed ID: 22074829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foxp3 and Toll-like receptor signaling balance T
    Gerriets VA; Kishton RJ; Johnson MO; Cohen S; Siska PJ; Nichols AG; Warmoes MO; de Cubas AA; MacIver NJ; Locasale JW; Turka LA; Wells AD; Rathmell JC
    Nat Immunol; 2016 Dec; 17(12):1459-1466. PubMed ID: 27695003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting Edge: TGF-β and Phosphatidylinositol 3-Kinase Signals Modulate Distinct Metabolism of Regulatory T Cell Subsets.
    Priyadharshini B; Loschi M; Newton RH; Zhang JW; Finn KK; Gerriets VA; Huynh A; Rathmell JC; Blazar BR; Turka LA
    J Immunol; 2018 Oct; 201(8):2215-2219. PubMed ID: 30209190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ex vivo induction of human CD103⁺ CD25hi Foxp3⁺ CD4⁺ and CD8⁺ Tregs is IL-2 and TGF-β1 dependent.
    Gunnlaugsdottir B; Maggadottir SM; Skaftadottir I; Ludviksson BR
    Scand J Immunol; 2013 Feb; 77(2):125-34. PubMed ID: 23126599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of alanyl-aminopeptidase on CD4+CD25+ regulatory T-cells enhances expression of FoxP3 and TGF-beta1 and ameliorates acute colitis in mice.
    Bank U; Tadje J; Täger M; Wolke C; Bukowska A; Ittenson A; Reinhold D; Helmuth M; Ansorge S; Shakespeare A; Vieth M; Malfertheiner P; Naumann M; Lendeckel U
    Int J Mol Med; 2007 Oct; 20(4):483-92. PubMed ID: 17786278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness.
    Piccirillo CA; Letterio JJ; Thornton AM; McHugh RS; Mamura M; Mizuhara H; Shevach EM
    J Exp Med; 2002 Jul; 196(2):237-46. PubMed ID: 12119348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein phosphatase 2A is a negative regulator of transforming growth factor-beta1-induced TAK1 activation in mesangial cells.
    Kim SI; Kwak JH; Wang L; Choi ME
    J Biol Chem; 2008 Apr; 283(16):10753-63. PubMed ID: 18299321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta 1 (TGF-beta1) and rapamycin synergize to effectively suppress human T cell responses via upregulation of FoxP3+ Tregs.
    Kawamoto K; Pahuja A; Hering BJ; Bansal-Pakala P
    Transpl Immunol; 2010 May; 23(1-2):28-33. PubMed ID: 20307666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated T-cell receptor and costimulatory signals determine TGF-β-dependent differentiation and maintenance of Foxp3+ regulatory T cells.
    Gabryšová L; Christensen JR; Wu X; Kissenpfennig A; Malissen B; O'Garra A
    Eur J Immunol; 2011 May; 41(5):1242-8. PubMed ID: 21469110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
    Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.